The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer

TY - JOUR

T1 - The impact of hospital attendance on COVID-19 infection in cancer patients

T2 - an assessment of data from Guy's Cancer

AU - Tremble, Kathryn

AU - Fox, Louis

AU - Moss, Charlotte

AU - Russell, Beth

AU - Aljazzaf, Haleema

AU - Higgins, Finola

AU - Dann, Bill

AU - Jogia, Vikash

AU - Roberts, Graham

AU - Rigg, Anne

AU - Dolly, Saoirse

AU - Van Hemelrijck, Mieke

PY - 2022/3/1

Y1 - 2022/3/1

N2 - Objective: The authors monitored positivity rates of asymptomatic SARS-CoV-2 tests during the second wave of COVID-19 at Guy's Cancer Centre. Methods: Logistic regression was used to investigate factors associated with asymptomatic COVID-19 positivity rates between 1 December 2020 and 28 February 2021 (n = 1346). Results: Living 20-40 km and 40-60 km from the alpha variant was associated with a reduced chance of a positive SARS-CoV-2 test compared with 0-20 km (odds ratio [OR]: 0.20; CI: 0.07-0.53 and OR: 0.38; CI: 0.15-0.98, respectively). An increased number of tests was associated with an increased chance of a positive SARS-CoV-2 test (OR: 1.10; CI: 1.04-1.16). Conclusion: The COVID-19 positivity rate of asymptomatic cancer patients is partly due to increased testing, with some contribution from the proximity of the patient population to the epicenter of the alpha variant.

AB - Objective: The authors monitored positivity rates of asymptomatic SARS-CoV-2 tests during the second wave of COVID-19 at Guy's Cancer Centre. Methods: Logistic regression was used to investigate factors associated with asymptomatic COVID-19 positivity rates between 1 December 2020 and 28 February 2021 (n = 1346). Results: Living 20-40 km and 40-60 km from the alpha variant was associated with a reduced chance of a positive SARS-CoV-2 test compared with 0-20 km (odds ratio [OR]: 0.20; CI: 0.07-0.53 and OR: 0.38; CI: 0.15-0.98, respectively). An increased number of tests was associated with an increased chance of a positive SARS-CoV-2 test (OR: 1.10; CI: 1.04-1.16). Conclusion: The COVID-19 positivity rate of asymptomatic cancer patients is partly due to increased testing, with some contribution from the proximity of the patient population to the epicenter of the alpha variant.

KW - alpha variant

KW - asymptomatic

KW - cancer

KW - COVID-19

KW - testing

UR - http://www.scopus.com/inward/record.url?scp=85126490412&partnerID=8YFLogxK

U2 - 10.2217/fon-2021-1329

DO - 10.2217/fon-2021-1329

M3 - Article

C2 - 35034514

AN - SCOPUS:85126490412

SN - 1744-8301

VL - 18

SP - 1211

EP - 1218

JO - Future oncology (London, England)

JF - Future oncology (London, England)

IS - 10

ER -